HM Payson & Co’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-60
| Closed | -$121 | – | 1166 |
|
|
2024
Q3 | $121 | Hold |
60
| – | – | ﹤0.01% | 1105 |
|
|
2024
Q2 | $100 | Hold |
60
| – | – | ﹤0.01% | 986 |
|
|
2024
Q1 | $363 | Hold |
60
| – | – | ﹤0.01% | 943 |
|
|
2023
Q4 | $422 | Hold |
60
| – | – | ﹤0.01% | 942 |
|
|
2023
Q3 | $525 | Hold |
60
| – | – | ﹤0.01% | 976 |
|
|
2023
Q2 | $705 | Hold |
60
| – | – | ﹤0.01% | 956 |
|
|
2023
Q1 | $1.03K | Hold |
60
| – | – | ﹤0.01% | 961 |
|
|
2022
Q4 | $1.57K | Hold |
60
| – | – | ﹤0.01% | 866 |
|
|
2022
Q3 | $6K | Hold |
60
| – | – | ﹤0.01% | 848 |
|
|
2022
Q2 | $8K | Hold |
60
| – | – | ﹤0.01% | 851 |
|
|
2022
Q1 | $9K | Hold |
60
| – | – | ﹤0.01% | 859 |
|
|
2021
Q4 | $13K | Hold |
60
| – | – | ﹤0.01% | 836 |
|
|
2021
Q3 | $12K | Hold |
60
| – | – | ﹤0.01% | 822 |
|
|
2021
Q2 | $14K | Hold |
60
| – | – | ﹤0.01% | 792 |
|
|
2021
Q1 | $20K | Buy |
60
+40
| +200% | +$16.3K | ﹤0.01% | 762 |
|
|
2020
Q4 | $7K | Buy |
+20
| New | +$7.7K | ﹤0.01% | 904 |
|
Other funds holding TFFP
HM Payson & Co's TFFP Position: Q4 2024 in Review
HM Payson & Co sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q4 2024, closing a stake of 60 shares — an estimated $121 sold.
HM Payson & Co first reported a position in TFFP in Q4 2020 and held it in 16 quarters. The position peaked at $20K in Q1 2021. 4 funds tracked by Wall St. Rank hold TFFP as of Q4 2024.
- HM Payson & Co reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
- HM Payson & Co sold 60 TFF Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $121.
- HM Payson & Co first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 16 quarters.
- HM Payson & Co's TFF Pharmaceuticals, Inc. Common Stock position peaked at $20K in Q1 2021.
- 4 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q4 2024.
Based on HM Payson & Co's 13F filing for Q4 2024, filed 7 Feb 2025.